Annual Cash & Cash Equivalents
$58.01 M
-$193.21 M-76.91%
December 31, 2023
Summary
- As of February 6, 2025, TYRA annual cash & cash equivalents is $58.01 million, with the most recent change of -$193.21 million (-76.91%) on December 31, 2023.
- During the last 3 years, TYRA annual cash & cash equivalents has risen by +$42.78 million (+281.02%).
- TYRA annual cash & cash equivalents is now -80.80% below its all-time high of $302.18 million, reached on December 31, 2021.
Performance
TYRA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$103.89 M
+$4.40 M+4.42%
September 30, 2024
Summary
- As of February 6, 2025, TYRA quarterly cash and cash equivalents is $103.89 million, with the most recent change of +$4.40 million (+4.42%) on September 30, 2024.
- Over the past year, TYRA quarterly cash and cash equivalents has increased by +$4.40 million (+4.42%).
- TYRA quarterly cash and cash equivalents is now -66.79% below its all-time high of $312.82 million, reached on September 30, 2021.
Performance
TYRA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TYRA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -76.9% | +4.4% |
| 3 y3 years | +281.0% | -66.8% |
| 5 y5 years | +10000.0% | -66.8% |
TYRA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.8% | at low | -65.6% | +79.1% |
| 5 y | 5-year | -80.8% | >+9999.0% | -66.8% | +582.4% |
| alltime | all time | -80.8% | >+9999.0% | -66.8% | +582.4% |
Tyra Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $103.89 M(+4.4%) |
| Jun 2024 | - | $99.49 M(-60.9%) |
| Mar 2024 | - | $254.37 M(+338.5%) |
| Dec 2023 | $58.01 M(-76.9%) | $58.01 M(-73.1%) |
| Sep 2023 | - | $215.65 M(-7.2%) |
| Jun 2023 | - | $232.41 M(-3.8%) |
| Mar 2023 | - | $241.70 M(-3.8%) |
| Dec 2022 | $251.21 M | $251.21 M(-4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $263.21 M(-4.3%) |
| Jun 2022 | - | $275.11 M(-5.9%) |
| Mar 2022 | - | $292.50 M(-3.2%) |
| Dec 2021 | $302.18 M(+1884.9%) | $302.18 M(-3.4%) |
| Sep 2021 | - | $312.82 M(+131.4%) |
| Jun 2021 | - | $135.20 M(+788.1%) |
| Dec 2020 | $15.22 M(>+9900.0%) | $15.22 M |
| Dec 2019 | $108.00 K | - |
FAQ
- What is Tyra Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tyra Biosciences?
- What is Tyra Biosciences annual cash & cash equivalents year-on-year change?
- What is Tyra Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Tyra Biosciences?
- What is Tyra Biosciences quarterly cash and cash equivalents year-on-year change?
What is Tyra Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of TYRA is $58.01 M
What is the all time high annual cash & cash equivalents for Tyra Biosciences?
Tyra Biosciences all-time high annual cash & cash equivalents is $302.18 M
What is Tyra Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, TYRA annual cash & cash equivalents has changed by -$193.21 M (-76.91%)
What is Tyra Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TYRA is $103.89 M
What is the all time high quarterly cash and cash equivalents for Tyra Biosciences?
Tyra Biosciences all-time high quarterly cash and cash equivalents is $312.82 M
What is Tyra Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, TYRA quarterly cash and cash equivalents has changed by +$4.40 M (+4.42%)